Matthew J Butler

Dr. Matthew J Butler serves as a Consultant Senior Lecturer and MRC Clinician Scientist at Bristol Medical School, University of Bristol. His clinical-academic role bridges medical practice with cutting-edge research in vascular biology and diabetic complications. Holding qualifications including BSc, MBChB, and PhD, he maintains active clinical duties alongside research leadership.

His research focuses on endothelial glycocalyx dysfunction in diabetes and kidney disease, with specialization in aldosterone-mediated vascular damage, albuminuria mechanisms, and glomerular filtration barrier pathology. Key areas include glycocalyx repair strategies, mineralocorticoid receptor signaling, and microvascular complication prevention. His work integrates molecular biology, animal models, and clinical translation.

Recent publications analyze adiponectin's protective effects on glomerular function (2024), heparanase inhibition for glycocalyx preservation (2024), and aldosterone's dual roles in vascular health (2023). His research demonstrates consistent focus on endothelial barrier integrity across diabetic nephropathy, hypertension, and metabolic syndrome.

As Co-Investigator on the MRC-funded project Determining The Therapeutic Potential Of Gene Therapy For Translation Of Glycocalyx Protection Strategies In Chronic Kidney Disease (2024-2025), he leads translational efforts toward clinical applications. His PhD thesis (Aldosterone-induced endothelial glycocalyx dysfunction, a potential therapeutic target in proteinuria?, 2018) established foundational work in this field.

His laboratory collaborates extensively with renal and vascular research groups, utilizing advanced techniques including intravital microscopy and genetic models. Current work emphasizes therapeutic glycocalyx restoration strategies for diabetic microvascular complications.